Percheron Therapeutics Limited (PER, formerly Antisense Therapeutics Limited) is a publicly listed biotechnology company focused on the development and commercialisation of novel therapies for oncology and rare diseases. The company's lead program is HMBD-002, a monoclonal antibody targeting the immune checkpoint regulator, VISTA.
Find out what a historical investment in Percheron Therapeutics would be worth today using our PER stock calculator.
Buying PER shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Percheron Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PER
What is the ticker symbol of Percheron Therapeutics?
The ticker symbol for Percheron Therapeutics is PER.
How much is one share of PER?
One share of PER is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of Percheron Therapeutics PER?
As of 20 November 2026 Percheron Therapeutics has a market cap of $5.95M.
What is the P/E ratio of PER?
The Price to Earnings ratio of PER is -0.73.
What is the Earnings Per Share of PER?
The Earnings Per Share of PER is -$0.00.
What is the 52-week high for Percheron Therapeutics stock?
The Percheron Therapeutics 52-week high stock price is $0.01.
What is the 52-week low for Percheron Therapeutics stock?
The Percheron Therapeutics 52-week low stock price is $0.00.
Can I buy PER shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PER shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.